Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-022091
Filing Date
2021-06-04
Accepted
2021-06-04 17:33:35
Documents
1
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5943
  Complete submission text file 0000899243-21-022091.txt   7320
Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
HERSHBERG ROBERT (Reporting) CIK: 0001274139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36076 | Film No.: 21997590

Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)